arginine has been researched along with Carcinoma, Oat Cell in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (27.87) | 18.7374 |
1990's | 34 (55.74) | 18.2507 |
2000's | 10 (16.39) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bessho, A; Hotta, K; Kiura, K; Segawa, Y; Shinkai, T; Tabata, M; Takigawa, N; Tanimoto, M; Ueoka, H; Umemura, S | 1 |
Bridle, H; Eisen, T; El Galta, R; Houlston, RS; Matakidou, A; Rudd, MF; Webb, EL | 1 |
Corbella, J; Estape, J; Firvida, J; Fuentes, M; Galan, C; Gene, M; Gomez-Catalan, J; Huguet, E; Rodamilans, M; To-Figueras, J | 1 |
Baber, GB; Boyd, JC; Malcolm, EK; Stoler, MH | 1 |
Bhoopalam, N; Robertson, GL; Zelkowitz, LJ | 1 |
Blum, RH; Ettinger, DS; Finkelstein, DM; Lincoln, ST; Ritch, PS | 1 |
Fan, Y; Huang, ZY; Sun, L; Zhang, YP | 1 |
Yue, X; Zang, QC | 1 |
Creech, RH; Ettinger, DS; Ferraro, JA; Ruckdeschel, JC; Tritchler, D; Vogl, SE; Woll, J | 1 |
Bork, E; Dombernowsky, P; Hansen, HH; Osterlind, K; Pedersen, AG | 1 |
Calciati, A; Conte, PF; Giaccone, G; Musella, R | 1 |
Eguchi, K; Etou, H; Miyachi, S; Morinari, H; Nakada, K; Noda, K; Ohe, Y; Ohkuni, Y; Watanabe, K; Yamada, Y | 1 |
Alberto, P; Bacchi, M; Cerny, T; Hürny, C; Joss, RA; Leyvraz, S; Ludwig, C; Martinelli, G; Stahel, R; Thürlimann, B | 1 |
Grant, SC; Kris, MG | 1 |
Gromova, II; Razin, SV; Thomsen, B | 1 |
Ettinger, DS | 1 |
Ardizzoni, A; Giaccone, G; Haaxma-Reiche, H; Kirkpatrick, A; Postmus, PE; Quoix, E; Sahmoud, T; Smit, EF; van Zandwijk, N | 1 |
Blanc-Jouvan, F; Brambilla, C; Moro, D; Mousseau, M; Nagy-Mignotte, H; Orfeuvre, H; Schaerer, R | 1 |
Muggia, FM | 1 |
Aapro, M; Alberto, P; Bauer, J; Leyvraz, S; Michel, G; Stahel, R | 1 |
Burghouts, JT; Haaxma-Reiche, H; Postmus, PE; van der Graaf, WT | 1 |
de Jong, S; de Vries, EG; Kooistra, AJ; Mulder, NH; Zijlstra, JG | 1 |
Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
Corringham, R; Corringham, S; Dhaliwal, H; Germond, C; Goss, GD; Rowen, J; Vincent, M | 1 |
Campling, BG; Jain, N; Lam, YM; Pym, J | 1 |
Bergman, B; Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, FR; Kristjansen, PE; Lassen, U; Osterlind, K; Sigsgaard, TC | 1 |
de Vries, EG; Keith, WN; Mulder, NH; Nienhuis, EF; Uges, DR; van der Graaf, WT; Withoff, S | 1 |
Beltran, GS; Canfield, VA; Crowley, JJ; Grozea, PN; Kingsbury, L; Laufman, LR; Livingston, RB; Ross, SW; Weiss, GR | 1 |
Cascinu, S; Catalano, G; Del Ferro, E; Graziano, F; Ligi, M | 1 |
Cellerino, R; Cetto, G; Graziano, F; Isidori, P; Mari, D; Pasini, F; Santo, A; Tummarello, D | 1 |
Ghaemmaghami, M; Jett, JR | 1 |
de Jong, RS; de Vries, EG; Groen, HJ; Höppener, FJ; Mulder, NH; Sleijfer, DT; Uges, DR; van der Graaf, WT; Willemse, PH | 1 |
Jin, X; Liu, Z; Luo, B; Yin, L; Zeng, P | 1 |
Clerico, M; Curran, D; Giaccone, G; Gregor, A; Groen, HJ; Haaxma-Reiche, H; Karnicka, H; Kirkpatrick, A; Lewinski, T; Postmus, PE; Sahmoud, T; Smit, EF; van Meerbeeck, J | 1 |
Bergman, AM; Jensen, PB; Munch-Petersen, B; Peters, GJ; Pinedo, HM; Sehested, M; Smid, K; Veerman, G; Voorn, DA | 1 |
Dombernowsky, P; Hansen, HH; Hirsch, FR; Ingeberg, S; Jeppesen, N; Kristensen, C; Osterlind, K; Sorensen, PG | 1 |
Fietkau, R | 1 |
Baker, LH; Fraile, RJ; Samson, MK; Talley, RW | 1 |
Bunn, PA; Ihde, DC; Radice, PA | 1 |
Beck, H; Capranico, G; Gazdar, AF; Giaccone, G; Zunino, F | 1 |
Bergman, B; Sörenson, S; Sullivan, M | 1 |
Kohn, KW; Orr, A; Pommier, Y; Riou, JF | 1 |
Bork, E; Dombernowsky, P; Hansen, HH; Hansen, M | 1 |
Corringham, R; Corringham, S; Dhaliwal, H; Germond, C; Goss, GD; Kane, G; Rowen, J; Sinoff, C; Vincent, M | 1 |
Giaccone, G | 1 |
Berendsen, HH; Haaxma-Reiche, H; Postmus, PE; Sleijfer, DT; Smit, EF | 1 |
Cellerino, R; Cetto, G; Isidori, P; Pasini, F; Tummarello, D | 1 |
Bergman, B; Bork, E; Dombernowsky, P; Ersbøll, J; Hansen, HH; Hansen, M | 1 |
Jakobsen, A; Nielsen, K; Schultz, H; Steenholdt, S; Sørensen, BT | 1 |
Calciati, A; Giaccone, G; Schmidt, G | 1 |
Cellerino, R; Di Furia, L; Gramazio, A; Guidi, F; Menichetti, E; Tummarello, D | 1 |
McVie, G; Muggia, FM | 1 |
D'Incalci, M; Figoli, F; Lestuzzi, C; Monfardini, S; Sorio, R; Tirelli, U; Urso, R; Zanette, ML | 1 |
Christensen, IJ; Hansen, HH; Roed, H; Spang-Thomsen, M; Vindeløv, LL | 1 |
Bonardi, GM; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Testore, F | 1 |
Brunner, KW; Cerny, T; Joss, RA; Pedrazzini, A | 1 |
Berendsen, HH; Haaxma-Reiche, H; Postmus, PE | 1 |
Bork, E; Dombernowsky, P; Hansen, HH; Hansen, M; Hansen, SW; Pedersen, AG | 1 |
Brattain, MG; Long, BH; Musial, ST | 1 |
Eguchi, K; Morinaga, S; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suga, J; Tamura, T | 1 |
8 review(s) available for arginine and Carcinoma, Oat Cell
Article | Year |
---|---|
New antineoplastic agents in lung cancer 1988-1993.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Irinotecan; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Paclitaxel; Teniposide; Vinblastine; Vinorelbine | 1995 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Salvage Therapy; Teniposide; Vincristine | 1995 |
[Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate; Teniposide; Treatment Outcome | 1994 |
Teniposide: overview of its therapeutic potential in adult cancers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide | 1994 |
New agents in the treatment of small cell lung cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Drugs, Investigational; Gemcitabine; Humans; Immunologic Factors; Irinotecan; Lung Neoplasms; Menogaril; Paclitaxel; Taxoids; Teniposide; Topotecan; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
Teniposide in the treatment of small cell lung cancer: a review.
Topics: Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Humans; Lung Neoplasms; Teniposide | 1992 |
Teniposide alone and in combination chemotherapy in small cell lung cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Administration Schedule; Humans; Lung Neoplasms; Teniposide | 1992 |
A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Retrospective Studies; Teniposide | 1989 |
19 trial(s) available for arginine and Carcinoma, Oat Cell
Article | Year |
---|---|
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Salvage Therapy; Survival; Teniposide; Treatment Outcome; Vincristine | 2002 |
[Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Teniposide; Treatment Outcome | 2002 |
[Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Rate; Teniposide | 2004 |
Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).
Topics: Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspartic Acid; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Phosphonoacetic Acid; Random Allocation; Teniposide; Zinostatin | 1984 |
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Teniposide; Thrombocytopenia; Treatment Outcome | 1994 |
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexa
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Palliative Care; Prospective Studies; Quality of Life; Surveys and Questionnaires; Survival Rate; Teniposide; Vincristine | 1995 |
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Salvage Therapy; Teniposide; Vincristine | 1995 |
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Cranial Irradiation; Europe; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Remission Induction; Teniposide; Thrombocytopenia; Tomography, X-Ray Computed | 1995 |
Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Teniposide | 1994 |
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Regression Analysis; Remission Induction; Survival Rate; Teniposide; Vincristine | 1996 |
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Teniposide; Treatment Outcome | 1997 |
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients wit
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 1997 |
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.
Topics: Adult; Aged; Alanine Transaminase; Alkenes; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Polyenes; Pyrones; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Teniposide | 2000 |
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesna; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2001 |
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Topics: Alopecia; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Evaluation; Etoposide; Humans; Leukemia; Leukopenia; Lung Neoplasms; Lymphoma; Podophyllotoxin; Teniposide | 1979 |
Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia | 1992 |
Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Prospective Studies; Teniposide | 1991 |
Treatment of extensive small cell lung cancer with carboplatin and teniposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Teniposide; Thrombocytopenia | 1991 |
35 other study(ies) available for arginine and Carcinoma, Oat Cell
Article | Year |
---|---|
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Carcinoma, Small Cell; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Medical Records; Middle Aged; Multivariate Analysis; Osmotic Pressure; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Vasopressins | 2007 |
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
Topics: Amino Acid Substitution; Arginine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Glycine; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Polymorphism, Single Nucleotide; Prognosis; Receptor, Fibroblast Growth Factor, Type 4; Survival Analysis | 2007 |
Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Alleles; Amino Acid Sequence; Arginine; Carcinoma; Carcinoma, Small Cell; Codon; Female; Gene Deletion; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Genotype; Glutathione Transferase; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Polymorphism, Genetic; Proline; Risk Factors; Smoking; Spain | 1996 |
Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
Topics: Adenocarcinoma; Alleles; Arginine; Carcinoma in Situ; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Codon; DNA, Neoplasm; Female; Gene Frequency; Homozygote; Humans; Neoplasm Invasiveness; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2000 |
Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone.
Topics: Adolescent; Adult; Arginine; Blood; Carcinoma, Small Cell; Cyclophosphamide; Humans; Leukemia, Lymphoid; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Osmolar Concentration; Peripheral Nervous System Diseases; Prednisone; Radioimmunoassay; Sodium; Urine; Vasopressins; Vincristine | 1973 |
Phase II study of teniposide in small cell carcinoma of the lung.
Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1984 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed | 1981 |
Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei.
Topics: Amsacrine; Antineoplastic Agents; Carcinoma, Small Cell; Cell Fractionation; Cell Line; Cell Nucleus; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Exons; Genes, myc; Humans; Lung Neoplasms; Restriction Mapping; Saline Solution, Hypertonic; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1995 |
Teniposide for meningeal carcinomatosis of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunologic Factors; Injections, Spinal; Interferon-gamma; Lung Neoplasms; Meningeal Neoplasms; Middle Aged; Morphine; Teniposide; Vincristine | 1993 |
Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
Topics: Amsacrine; Carcinoma, Small Cell; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Humans; Lung Neoplasms; Teniposide; Tumor Cells, Cultured | 1993 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Combination chemotherapy with teniposide (VM26) and carboplatin in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Analysis; Teniposide | 1993 |
Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cadmium; Cadmium Chloride; Carcinoma, Small Cell; Cell Line; Chlorides; Cisplatin; Cross Reactions; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Lung Neoplasms; Metallothionein; Platinum Compounds; Podophyllotoxin; Teniposide; Tumor Cells, Cultured; Vinca Alkaloids | 1996 |
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Topics: Amsacrine; Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Small Cell; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Humans; In Situ Hybridization, Fluorescence; Isoenzymes; Lung Neoplasms; Mitoxantrone; Multidrug Resistance-Associated Proteins; RNA, Messenger; RNA, Neoplasm; Teniposide; Tumor Cells, Cultured | 1996 |
The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Bone Marrow; Carcinoma, Small Cell; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Nausea; Neoplasm Staging; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia; Vomiting | 1997 |
[VP-16 and VM-26 plus platinum drugs combined with radiotherapy in the treatment of small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Teniposide | 1998 |
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Carcinoma, Small Cell; Cell Survival; Cytarabine; Cytidine Deaminase; Daunorubicin; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Guanosine Triphosphate; Humans; Lung Neoplasms; Nucleoside Deaminases; Teniposide; Thymidine Kinase; Tumor Cells, Cultured; Uridine Triphosphate | 2001 |
[Controversial treatment of brain metastases of small-cell lung cancer. Randomized comparison of chemotherapy alone and radiochemotherapy].
Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Lung Neoplasms; Neurologic Examination; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Teniposide; Treatment Outcome | 2001 |
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Teniposide; Thrombocytopenia | 1978 |
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Northern; Blotting, Southern; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Line; Cell Survival; Cisplatin; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Phenotype; Restriction Mapping; RNA, Neoplasm; Teniposide | 1992 |
Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.
Topics: Aged; Attitude to Health; Carcinoma, Small Cell; Etoposide; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Neoplasm Staging; Probability; Quality of Life; Surveys and Questionnaires; Teniposide | 1992 |
Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
Topics: Amsacrine; Animals; Base Sequence; Binding Sites; Carcinoma, Small Cell; Cell Line; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Genes, myc; Humans; Leukemia L1210; Lung Neoplasms; Mice; Molecular Sequence Data; Promoter Regions, Genetic; Restriction Mapping; Substrate Specificity; Teniposide | 1992 |
Treatment of brain metastases of small cell lung cancer with teniposide.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials, Phase II as Topic; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Teniposide; Thrombocytopenia | 1992 |
Teniposide as single drug therapy for elderly patients affected by small cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Teniposide; Treatment Outcome | 1992 |
Pilot study of teniposide in combination chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Pilot Projects; Teniposide; Vincristine | 1991 |
Treatment strategies in relation to drug action.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; DNA Topoisomerases, Type II; Etoposide; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Podophyllotoxin; Teniposide | 1987 |
Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Pericardium; Podophyllotoxin; Teniposide | 1987 |
The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Organoplatinum Compounds; Teniposide; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1988 |
Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1988 |
Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Topics: Aged; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Prognosis; Teniposide | 1988 |
Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).
Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Podophyllotoxins for brain metastases of small cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Teniposide | 1988 |
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Topics: Aged; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide | 1986 |
DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Topics: Adenocarcinoma; Adenosine Triphosphate; Carcinoma, Small Cell; Cell Division; Cell Nucleus; Cells, Cultured; DNA; DNA, Single-Stranded; Drug Resistance; Etoposide; Humans; Intercalating Agents; Lung Neoplasms; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1986 |
A case of small cell lung cancer successfully treated with VM26.
Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Male; Podophyllotoxin; Teniposide | 1986 |